首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Antimicrobial and Anticoagulant Activities of N-Chlorotaurine NN-Dichloro-22-Dimethyltaurine and N-Monochloro-22-Dimethyltaurine in Human Blood
【2h】

Antimicrobial and Anticoagulant Activities of N-Chlorotaurine NN-Dichloro-22-Dimethyltaurine and N-Monochloro-22-Dimethyltaurine in Human Blood

机译:N-氯牛磺酸NN-二氯-22-二甲基牛磺酸和N-一氯-22-二甲基牛磺酸的抗微生物和抗凝血活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to determine the potential application of N-chlorotaurine (NCT), N,N-dichloro-2,2-dimethyltaurine (NVC-422), and N-monochloro-2,2-dimethyltaurine (NVC-612) as catheter lock solutions for the prevention of catheter blockage and catheter-related bloodstream infections by testing their anticoagulant and broad-spectrum antimicrobial activities in human blood. NCT, NVC-422, NVC-612, and control compounds were serially diluted in fresh human blood to evaluate the effects on prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen, and direct thrombin inhibition. Quantitative killing assays against pathogens, including methicillin-resistant Staphylococcus aureus, Escherichia coli, and Candida albicans, were performed in the presence of heparin and human blood. NCT and NVC-612 (1.38 mM each) and 1.02 mM NVC-422 prolonged prothrombin time (Quick value, 17 to 30%), activated partial thromboplastin time 3- to 4-fold to 76 to 125 s, and thrombin time 2- to 4-fold to 34 to 68 s. Fibrinogen decreased from 258 to 283 mg/dl (range of controls) to <40 mg/dl. No direct thrombin inhibition was observed by NVC-422 or NVC-612. Heparin did not influence the bactericidal activity of NCT. The microbicidal activities of NCT, NVC-422, and NVC-612 were maintained in diluted human blood. NCT, NVC-612, and NVC-422 have broad-spectrum antimicrobial activity in blood and anticoagulant activity targeting both intrinsic and extrinsic pathways of the coagulation system. These properties support their application as catheter lock solutions.
机译:这项研究的目的是确定N-氯牛磺酸(NCT),N,N-dichloro-2,2-二甲基牛磺酸(NVC-422)和N-monochloro-2,2-二甲基牛磺酸(NVC-612)的潜在应用)作为导管锁定解决方案,可通过测试其在人血中的抗凝和广谱抗菌活性来预防导管阻塞和与导管相关的血液感染。在新鲜人血中连续稀释NCT,NVC-422,NVC-612和对照化合物,以评估对凝血酶原时间,活化的部分凝血活酶时间,凝血酶时间,纤维蛋白原和直接凝血酶抑制的影响。在肝素和人血存在下,针对包括耐甲氧西林的金黄色葡萄球菌,大肠埃希氏菌和白色念珠菌在内的病原体进行定量杀灭测定。 NCT和NVC-612(各自为1.38 mM)和1.02 mM NVC-422延长了凝血酶原时间(快速值,为17%到30%),活化的部分凝血活酶时间为3到4倍,至76到125 s,凝血酶时间为2倍至4倍至34至68 s。纤维蛋白原从258降至283 mg / dl(对照范围)至<40 mg / dl。 NVC-422或NVC-612未观察到直接的凝血酶抑制作用。肝素不影响NCT的杀菌活性。 NCT,NVC-422和NVC-612的杀微生物活性在稀释的人血中得以维持。 NCT,NVC-612和NVC-422在血液中具有广谱抗菌活性,并具有针对凝血系统内在和外在途径的抗凝活性。这些特性支持其作为导管锁定解决方案的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号